Evaluation of Cytotoxic and Tyrosinase Inhibitory Activities of 2-phenoxy(thiomethyl) pyridotriazolopyrimidines: In Vitro and Molecular Docking Studies-Reference-Cited by-同舟云学术

Evaluation of Cytotoxic and Tyrosinase Inhibitory Activities of 2-phenoxy(thiomethyl) pyridotriazolopyrimidines: In Vitro and Molecular Docking Studies

Published:2020-10-14 Issue:14 Volume:20 Page:1714-1721
ISSN:1871-5206
Container-title:Anti-Cancer Agents in Medicinal Chemistry
language:en
Short-container-title:ACAMC

Author:

Abuelizz Hatem A.¹^ORCID,Anouar El Hassane²,Marzouk Mohamed³,Hasan Mizaton H.⁴,Saleh Siti R.⁴,Ahudhaif Adi⁵,Alburikan Khalid A.⁶,Al-Salahi Rashad¹

Affiliation:

1. Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia

2. Department of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam bin Abdulaziz University, Al-kharj 11942, Saudi Arabia

3. Department of Tanning Materials and Leather Technology, Chemistry of Natural Products Group (Center of Excellence for Advanced Sciences), National Research Centre, 33 El-Bohouth St. (Former El-Tahrir St.), Dokki, Cairo 12622, Egypt

4. Department of Pharmaceutical Chemistry and Pharmacology, Faculty of Pharmacy, Campus Puncak Alam, Universiti Teknologi MARA (UiTM), 42300 Bandar Puncak Alam, Selangor, Malaysia

5. Department of Computer Science, College of Computer Engineering and Sciences in Al-kharj, Prince Sattam bin Abdulaziz University, P.O. Box 151, Al-kharj 11942, Saudi Arabia

6. Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia

Abstract

Background: The use of tyrosinase has confirmed to be the best means of recognizing safe, effective, and potent tyrosinase inhibitors for whitening skin. Twenty-four 2-phenoxy(thiomethyl)pyridotriazolopyrimidines were synthesized and characterized in our previous studies. Objective: The present work aimed to evaluate their cytotoxicity against HepG2 (hepatocellular carcinoma), A549 (pulmonary adenocarcinoma), MCF-7 (breast adenocarcinoma) and WRL 68 (embryonic liver) cell lines. Methods: MTT assay was employed to investigate the cytotoxicity, and a tyrosinase inhibitor screening kit was used to evaluate the Tyrosinase (TYR) inhibitory activity of the targets. Results: The tested compounds exhibited no considerable cytotoxicity, and nine of them were selected for a tyrosinase inhibitory test. Compounds 2b, 2m, and 5a showed good inhibitory percentages against TYR compared to that of kojic acid (reference substance). Molecular docking was performed to rationalize the Structure-Activity Relationship (SAR) of the target pyridotriazolopyrimidines and analyze the binding between the docked-selected compounds and the amino acid residues in the active site of tyrosinase. Conclusion: The target pyridotriazolopyrimidines were identified as a new class of tyrosinase inhibitors.

Funder

King Saud University

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Pharmacology,Molecular Medicine

Reference26 articles.

1. Ielo L.; Deri B.; Germanò M.P.; Vittorio S.; Mirabile S.; Gitto R.; Rapisarda A.; Ronsisvalle S.; Floris S.; Pazy Y.; Fais A.; Fishman A.; De Luca L.; Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile. Eur J Med Chem 2019,178,380-389

2. Bang E.; Noh S.G.; Ha S.; Jung H.J.; Kim D.H.; Lee A.K.; Hyun M.K.; Kang D.; Lee S.; Park C.; Moon H.R.; Chung H.Y.; Evaluation of the novel synthetic tyrosinase inhibitor (Z)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) in vitro and in silico. Molecules 2018,23(12),12

3. Lee S.; Ullah S.; Park C.; Won Lee H.; Kang D.; Yang J.; Akter J.; Park Y.; Chun P.; Moon H.R.; Inhibitory effects of N-(acryloyl)benzamide derivatives on tyrosinase and melanogenesis. Bioorg Med Chem 2019,27(17),3929-3937

4. Jiménez M.; Chazarra S.; Escribano J.; Cabanes J.; García-Carmona F.; Competitive inhibition of mushroom tyrosinase by 4-substituted benzaldehydes. J Agric Food Chem 2001,49(8),4060-4063

5. Yi W.; Dubois C.; Yahiaoui S.; Haudecoeur R.; Belle C.; Song H.; Hardré R.; Réglier M.; Boumendjel A.; Refinement of arylthiosemicarbazone pharmacophore in inhibition of mushroom tyrosinase. Eur J Med Chem 2011,46(9),4330-4335

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significant pharmacological activities of benzoquinazolines scaffold;Pharmacological Reports;2023-02-06

2. Biological Evaluation of 4-(1H-triazol-1-yl)benzoic Acid Hybrids as Antioxidant Agents: In Vitro Screening and DFT Study;Applied Sciences;2021-12-08